Intraosseous Infusion Devices Market Size to Exceed USD 1,607.0 Mn by 2032

The Intraosseous Infusion Devices Market, estimated at USD 1,112.1 Mn in 2025, is expected to exhibit a CAGR of 5.4% and reach USD 1,607.0 Mn by 2032.

The industry is witnessing significant growth driven by rising demand for advanced, reliable, and cost-effective medical devices across diagnostic, therapeutic, and monitoring applications. Rapid advancements in device design, digital health integration, and adoption of minimally invasive technologies are reshaping the competitive landscape. Furthermore, supportive regulatory frameworks, increasing healthcare investments, and the growing focus on patient-centric care are expected to create new growth avenues for market players.

Key market players are focusing on adoption of  growth strategies such as launch of new products that can meet the growing demand for intraosseous infusion device due to increasing cases of cardiac arrest, trauma cases, road injusries, and others. For instance, in 2025, according to American Heart Association, approximately 19.1 million deaths are due to CVD globally. The age-adjusted death rate per 100,000 population was 239.8. The age-adjusted prevalence rate was 7354.1 per100,000.

Global Intraosseous Infusion Devices Market– Impact of Coronavirus (COVID-19) Pandemic

The World Health Organization (WHO) designated the illness caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which first appeared in Wuhan (province of Hubei, China), in the last months of 2025, as "coronavirus disease 2025" or COVID-19. This virus spreads quickly, and had a serious negative impact on the economies, social behaviors, and healthcare of every country in the world.

COVID-19 affected the economy in three main ways: by directly affecting production and demand, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to the lockdown, several countries such as India, China, Brazil, and others faced problems regarding transportation of things from one place to another.

COVID-19 had a positive impact on the global intraosseous infusion devices market. The device was used inn various cardiac disorders associated with COVID-19.

Browse 36 Market Data Tables and 26 Figures spread through 180 Pages and in-depth TOC on “Global Intraosseous Infusion Devices Market”- Forecast to 2032, Global Intraosseous infusion devices Market, By Product Type (FAST 1 Device, FAST x Device, Bone Injection Gun (BIG) Devices, EZ-IO Device, NIO Device, Dieckmann Modified Needle, and Jamshidi Needle), By Technology (Manual IO Needles, Battery Powered Driver, and Impact Driven Devices), By End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Others),  and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa).

To know the latest trends and insights prevalent in this market, click the link below:

https://www.coherentmarketinsights.com/market-insight/intraosseous-infusion-devices-market-507

Key Takeaways of the Global Intraosseous Infusion Devices Market:

• the global intraosseous infusion devices market is expected to exhibit a CAGR of 5.4% during the forecast period. The merger with emerging economies offers lucrative growth opportunities for players in the global intraosseous infusion devices market.
• Among prodyct type, the FAST 1 device segment is expected to hold a dominant position in the global intraosseous infusion devices market during the forecast period due to technological advancements in the field of surgical equipments and need for better assistance during CPR. For instance, according to the American Heart Association report, in 2022, the cardiac arrest remains a public health crisis. More than 356,000 out-of-hospital cardiac arrests (OHCA) are reported annually in the U.S., nearly 90% of them fatal. The incidence of EMS-assessed non-traumatic OHCA in people of any age is estimated to be 356,461, or nearly 1,000 people each day. Survival to hospital discharge after EMS-treated cardiac arrest languishes at about 10%.
• Among region, North America is expected to be the dominant region in the global intraosseous infusion devices market as key players are focusing on organic strategies to start new product launches
• Major players operating in the global intraosseous infusion devices market are PerSys Medical, Aero Healthcare AU Pty Ltd, Teleflex Incorporated, PAVmed Inc., BIOPSYBELL S.R.L., Becton Dickinson Company, Cook Group, SAM Medical, Argon Medical Devices, Inc., Cardinal Health, Inc., StarFish Product Engineering Inc., and Medax SRL unipersonle